Elbit selects restructuring adviser

Article

Israel-based Elbit has chosen Salomon Brothers of New York Cityas its financial adviser and investment banker to help plan aproposed corporate reorganization. Salomon Brothers will help Elbit managers examine the feasibilityof realigning Elbit and its

Israel-based Elbit has chosen Salomon Brothers of New York Cityas its financial adviser and investment banker to help plan aproposed corporate reorganization.

Salomon Brothers will help Elbit managers examine the feasibilityof realigning Elbit and its subsidiaries into new and independenthealthcare, defense and commercial companies. Elbit's board ofdirectors approved this examination in principle on Dec. 7 (SCAN12/27/95).

The selection of Salomon Brothers as financial adviser is oneof two interim steps toward a final reorganization plan, accordingto Dr. Thomas Spackman, president of Elscint's U.S. subsidiary.The selection of a management consultant to help guide planningis still pending, he said.

In other Elscint news, the company's shareholders have approvedthe sale of Elscint's Elscintec ultrasound subsidiary to Elbit.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.